A recombinant human adenovirus expressing the simian immunodeficiency virus Gag antigen can induce long-lived immune responses in mice

Journal of General Virology

Volumn 78, Issue 5, 1997, Pages 991-997

  Flanagan, Brian ^a   Pringle, Craig R ^a   Leppard, Keith N ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXPRESSION VECTOR; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; IMMUNIZATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS RECOMBINANT;

EID: 0030962304     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-78-5-991     Document Type: Article

References (33)

1. Almond, N., Page, M., Mills, K., Jenkins, A., Ling, C., Thorpe, R. & Kitchen, P. (1990). The production and purification of PCR-derived recombinant simian immunodeficiency virus p27 gag; its use in detecting serological and T-cell responses in macaques. Journal of Virological Methods 28, 321-326.
2. Bett, A. J., Prevee, L. & Graham, F. L. (1993). Packaging capacity and stability of human adenovirus type 5 vectors. Journal of Virology 67, 5911-5921.
3. Both, G. W., Lockett, L. J., Janardhana, V., Edwards, S. J., Bellamy, A. R., Graham, F. L., Prevee, L. & Andrews, M. E. (1993). Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc. Virology 193, 940-950.
4. Bourgault, I., Villefroy, P., Beyer, C., Aubertin, A.-M., Levy, J.-P. & Venet, A. (1993). Cytotoxic T-cell response and AIDS-free survival in simian immunodeficiency virus-infected macaques. AIDS 7, S73-S79.
5. Brookes, R., Bergmeier, L. A., Mitchell, E., Walker, J., Tao, L., Klavinskis, L., Meyers, N. J., Layton, G., Adams, S. E. & Lehner, T. (1995). Generation of diversity in the hierarchy of T-cell epitope responses following different routes of immunization with simian immunodeficiency virus protein. AIDS 9, 1017-1024.
6. Caravokyri, C., Pringle, C. R. & Leppard, K. N. (1993). Human adenovirus type 5 recombinants expressing simian immunodeficiency virus macaque strain gag antigen. Journal of General Virology 74, 2819-2824.
7. Daniel, M D., Kirchoff, F., Czajak, S. C., Sehgal, P. K. & Desrosiers, R. C. (1992). Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941.
8. Dormont, D., Legrand, R., Cranage, M., Greenaway, P., Hunsmann, G., Stahl-Hennig, C., Rossi, G., Verani, P., Stott, J., Kitchin, P., Osterhaus, A., Devries, P., Kurth, R., Norley, S., Heeney, J., Biberfeld, G. & Putkonen, P. (1995). Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. Vaccine 13, 295-300.
9. Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K., Stewart, M., Stephenson, J. R. & Wilkinson, G. W. G. (1995). High level expression of the measles virus nucleocapsid protein by using a replication-deficient adenovirus vector: induction of an MHC-1-restricted CTL response and protection in a murine model. Virology 210, 456-465.
10. Gallichan, W. S., Johnson, D. C., Graham, F. L. & Rosenthal, K. L. (1993). Mucosal immunity and protection after intranasal immunisation with a recombinant adenovirus expressing herpes simplex glycoprotein B. Journal of Infectious Diseases 168, 622-629.
11. + nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine 1, 1167-1173.
12. Ganne, V., Eloit, M., Laval, A., Adam, M. & Trouve, G. (1994). Enhancement of the efficacy of a replication-defective adenovirus-vectored vaccine by the addition of oil adjuvants. Vaccine 12, 1190-1196.
13. Graham, F. L., Smiley, J., Russel, W. C. & Nairn, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. Journal of General Virology 36, 59-72.
14. Hu, S.-L. (1996). Recombinant subunit vaccines against primate lentiviruses. AIDS Research and Human Retroviruses 12, 451-453.
15. Hu, S.-L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Ianglois, A. J., Kuller, L., Morton, W. R. & Benveniste, R. E. (1992). Protection of macaques against SIV infection by subunit vaccines of SFV envelope glycoprotein gp160. Science 255, 456-459.
16. Imler, J.-P. (1995). Adenovirus vectors as recombinant viral vaccines. Vaccine 13, 1143-1151.
17. Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. R. (1992). High-level expression of the tick-bome encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. Journal of Virology 66, 2086-2095.
18. Klessig, D. F. & Grodzicker, T. (1979). Mutations that allow human Ad2 and Ad5 to express late genes in monkey cells map in the viral gene encoding the 72k DNA binding protein. Cell 17, 957-966.
19. Knuijer, W., van Schaik, F. M. A. & Sussenbach, J. S. (1981). Structure and organisation of the gene coding for the DNA binding protein of adenovirus type 5. Nucleic Acids Research 9, 4439-4457.
20. Lehner, T., Wang, Y. F., Cranage, M., Bergmeier, L. A., Mitchell, E., Tao, L., Hall, G., Dennis, M., Cook, N., Brookes, R., Klavinskis, L., Doyle, C. & Ward, R. (1996). Protective mucosal immunity elicited by targeted iliac lymph-node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Medicine, 2, 767-775.
21. Lubeck, M. D., Davis, A. R., Chengalvala, M., Natuk, R. J., Morin, J. E., Molnar-Kimber, K., Mason, B. B., Bhat, B. M., Mizutani, S., Hung, P. P. & Purcell R. H. (1989). Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proceedings of the National Academy of Sciences, USA 86, 6763-6767.
22. Lubeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. R., Murthy, K. K., Murthy, S., Mizutani, S., Lee, S.-G., Wade, M. S., Bhat, B. M., Bhat, R., Dheer, S. K., Eichberg, J. W., Davis, A. R. & Hung, P. P. (1994). Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Research and Human Retroviruses 10, 1443-1449.
23. McMichael, A. J., Michie, C. A., Gotch, F. M., Smith, G. L. & Moss, B. (1986). Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. Journal of General Virology 67, 719-726.
24. Mittal, S. K., Middleton, D. M., Tikoo, S. K. & Babiuk, L. A. (1995). Pathogenesis and immunogenicity of bovine adenovirus type 3 in cotton rats (Sigmodon hispidus). Virology 213, 131-139.
25. Natuk, R. J., Lubeck, M. D., Chanda, P. K., Chengalvala, M., Wade, M. S., Murthy, S. C. S., Wilhelm, J., Vernon, S. K., Dheer, S. K., Mizutani, S., Lee, S.-G., Murthy, K. K., Eichberg, J. W., Davis, A. R. & Hung, P. P. (1993). Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees, AIDS Research and Human Retroviruses 9, 395-404.
26. Prevec, L., Schneider, M., Rosenthal, K. L., Belbeck, L. W., Derbyshire, J. B. & Graham, F. L. (1989). Use of human adenovirus-based vectors for antigen expression in animals. Journal of General Virology 70, 429-434.
27. Prevec, L., Campbell, J. B., Christie, B. S., Belbeck, L. & Graham, F. L. (1990). A recombinant human adenovirus vaccine against rabies. Journal of Infectious Diseases 161, 27-30.
28. Prevec, L., Christie, B. S., Laurie, K. E., Bailey, M. M., Graham, F. L. & Rosenthal, K. L. (1991). Immune responses to HIV-1 Gag antigens induced by recombinant adenovirus vectors in mice and rhesus macaque monkeys. Journal of Acquired Immune Deficiency Syndromes 4, 568-576.
29. Rowland-Jones, S. L. & McMichael, A. (1995). Immune responses in HIV-exposed seronegatives: have they repelled the virus? Current Opinion in Immunology 7, 448-455.
30. Top, F. H., Grossman, R. A., Bartelloni, P. J., Segal, H. E., Dudding, B. A., Russell, P. K. & Buscher, E. L. (1971). Immunisation with live types 7 and 4 adenovirus vaccines. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans. Journal of Infectious Diseases 124, 148-154.
31. Vaslin, B., Le Grand, R., Vogt, G., Benveniste, O., Gras, G., Roques, P., Stoeckel, P., Salk, P. L., Salk, J. & Dormont, D. (1994). Induction of humoral and cellular immunity to simian immunodeficiency virus: what are the requirements for protection? Vaccine 12, 1132-1139.
32. Wesseling, J. G., Godeke, G-J., Schijns, V. E. C. J., Prevec, L., Graham, F. L., Horzinek, M. C. & Rottier, P. J. M. (1993). Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection. Journal of General Virology 74, 2061-2069.
33. Wraith, D. C, Vessey, A. E. & Askonas, B. A. (1987). Purified influenza virus nucleoprotein protects mice from lethal infection. Journal of General Virology 68, 433-440.